These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23653393)

  • 21. Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.
    Woodworth BA
    Laryngoscope; 2015 Oct; 125 Suppl 7(0 7):S1-S13. PubMed ID: 25946147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of a Yellow fluorescent protein-based iodide influx high-throughput screening assay for cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
    Sui J; Cotard S; Andersen J; Zhu P; Staunton J; Lee M; Lin S
    Assay Drug Dev Technol; 2010 Dec; 8(6):656-68. PubMed ID: 21050066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAST205 competes with cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand for binding to CFTR to regulate CFTR-mediated fluid transport.
    Ren A; Zhang W; Yarlagadda S; Sinha C; Arora K; Moon CS; Naren AP
    J Biol Chem; 2013 Apr; 288(17):12325-34. PubMed ID: 23504457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CFTR pharmacology and its role in intestinal fluid secretion.
    Thiagarajah JR; Verkman AS
    Curr Opin Pharmacol; 2003 Dec; 3(6):594-9. PubMed ID: 14644010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.
    Zhang W; Fujii N; Naren AP
    Future Med Chem; 2012 Mar; 4(3):329-45. PubMed ID: 22393940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/deltaF508-CFTR to the plasma membrane.
    Davezac N; Tondelier D; Lipecka J; Fanen P; Demaugre F; Debski J; Dadlez M; Schrattenholz A; Cahill MA; Edelman A
    Proteomics; 2004 Dec; 4(12):3833-44. PubMed ID: 15529338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.
    Sloane PA; Shastry S; Wilhelm A; Courville C; Tang LP; Backer K; Levin E; Raju SV; Li Y; Mazur M; Byan-Parker S; Grizzle W; Sorscher EJ; Dransfield MT; Rowe SM
    PLoS One; 2012; 7(6):e39809. PubMed ID: 22768130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
    Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional regulation of cystic fibrosis transmembrane conductance regulator-containing macromolecular complexes: a small-molecule inhibitor approach.
    Zhang W; Penmatsa H; Ren A; Punchihewa C; Lemoff A; Yan B; Fujii N; Naren AP
    Biochem J; 2011 Apr; 435(2):451-62. PubMed ID: 21299497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation.
    Rapino D; Sabirzhanova I; Lopes-Pacheco M; Grover R; Guggino WB; Cebotaru L
    PLoS One; 2015; 10(3):e0119796. PubMed ID: 25799511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis transmembrane conductance regulator (CFTR): Making an ion channel out of an active transporter structure.
    Linsdell P
    Channels (Austin); 2018; 12(1):284-290. PubMed ID: 30152709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.
    Kunzelmann K; Nitschke R
    Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
    Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.
    Michaels WE; Bridges RJ; Hastings ML
    Nucleic Acids Res; 2020 Jul; 48(13):7454-7467. PubMed ID: 32520327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
    Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
    J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients.
    Boj SF; Vonk AM; Statia M; Su J; Vries RR; Beekman JM; Clevers H
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface.
    Chin S; Yang D; Miles AJ; Eckford PDW; Molinski S; Wallace BA; Bear CE
    J Biol Chem; 2017 Feb; 292(5):1988-1999. PubMed ID: 28003367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct Measurement of Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator to the Cell Surface and Binding to a Chemical Chaperone.
    Zhang Z; Baksh MM; Finn MG; Heidary DK; Richards CI
    Biochemistry; 2017 Jan; 56(1):240-249. PubMed ID: 28001373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological evaluation of cystic fibrosis conductance transmembrane regulator (CFTR) expression in human monocytes.
    Ettorre M; Verzè G; Caldrer S; Johansson J; Calcaterra E; Assael BM; Melotti P; Sorio C; Buffelli M
    Biochim Biophys Acta; 2014 Oct; 1840(10):3088-95. PubMed ID: 25046381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.